DK372089A - Anvendelse af isoquinolinderivater - Google Patents
Anvendelse af isoquinolinderivater Download PDFInfo
- Publication number
- DK372089A DK372089A DK372089A DK372089A DK372089A DK 372089 A DK372089 A DK 372089A DK 372089 A DK372089 A DK 372089A DK 372089 A DK372089 A DK 372089A DK 372089 A DK372089 A DK 372089A
- Authority
- DK
- Denmark
- Prior art keywords
- isoquinoline derivatives
- isoquinoline
- derivatives
- Prior art date
Links
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical class C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22630588A | 1988-07-29 | 1988-07-29 | |
US07/302,720 US4910206A (en) | 1986-07-14 | 1989-01-27 | 5-hetero-or aryl-substituted-imidazo(2,1-a)isoquinolines and their use as PAF receptor antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
DK372089D0 DK372089D0 (da) | 1989-07-27 |
DK372089A true DK372089A (da) | 1990-01-30 |
Family
ID=26920416
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK372089A DK372089A (da) | 1988-07-29 | 1989-07-27 | Anvendelse af isoquinolinderivater |
Country Status (16)
Country | Link |
---|---|
US (1) | US4910206A (es) |
EP (1) | EP0357550B1 (es) |
JP (1) | JPH0273016A (es) |
KR (1) | KR910002445A (es) |
AU (1) | AU632487B2 (es) |
CA (1) | CA1336503C (es) |
DE (1) | DE68913397T2 (es) |
DK (1) | DK372089A (es) |
ES (1) | ES2062092T3 (es) |
FI (1) | FI893616A (es) |
HU (1) | HU206040B (es) |
IE (1) | IE63243B1 (es) |
IL (1) | IL91128A (es) |
NO (1) | NO177485C (es) |
NZ (1) | NZ230098A (es) |
PT (1) | PT91302B (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0345931B1 (en) * | 1988-04-27 | 1993-01-20 | Schering Corporation | Certain paf antagonist/antihistamine combinations and methods |
US5639782A (en) * | 1992-03-04 | 1997-06-17 | Center For Innovative Technology | Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors |
US5530141A (en) * | 1992-03-04 | 1996-06-25 | Center For Innovative Technology | 2,4-diaryl-1,3-dithiolanes; 2,4-diaryl-1,3-dioxolanes; 2,4-diaryl-1,3-oxathiolanes; and 2,5-diaryl-1,3-oxathiolanes for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
US5463083A (en) * | 1992-07-13 | 1995-10-31 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
PT650485E (pt) | 1992-07-13 | 2001-03-30 | Millennium Pharm Inc | 2,5-diaril-tetra-hidro-tiofenos -furanos e analogos para o tratamento de desordens inflamatorias e imunitarias |
US5358938A (en) * | 1992-07-13 | 1994-10-25 | Cytomed, Inc. | Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
US5434151A (en) * | 1992-08-24 | 1995-07-18 | Cytomed, Inc. | Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
US5648486A (en) * | 1992-07-13 | 1997-07-15 | Cytomed, Inc. | Compounds and methods for the treatment of inflammatory and immune disorders |
US5703093A (en) * | 1995-05-31 | 1997-12-30 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
US5750565A (en) | 1995-05-25 | 1998-05-12 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
US5792776A (en) * | 1994-06-27 | 1998-08-11 | Cytomed, Inc., | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
FR2756560A1 (fr) * | 1996-12-04 | 1998-06-05 | Adir | Nouveaux derives de l'imidazoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
CN1076728C (zh) * | 1999-02-05 | 2001-12-26 | 浙江大学 | 2-芳基咪唑并[2,1-a]异喹啉的衍生物及其用途 |
WO2021057696A1 (zh) * | 2019-09-27 | 2021-04-01 | 隆泰申医药科技(南京)有限公司 | 一种杂芳基类化合物及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4101553A (en) * | 1974-01-02 | 1978-07-18 | Sandoz, Inc. | Imidazo[2,1-a]isoquinolines |
HU172649B (hu) * | 1975-04-24 | 1978-11-28 | Gyogyszerkutato Intezet | Sposob poluchenija novykh biologicheski aktivnykh lizergamidov |
ATE74357T1 (de) * | 1986-07-14 | 1992-04-15 | Sandoz Ag | 5-hetero- oder -aryl-substituierte imidazo(2,1a>isochinoline. |
-
1989
- 1989-01-27 US US07/302,720 patent/US4910206A/en not_active Expired - Fee Related
- 1989-07-18 HU HU893613A patent/HU206040B/hu not_active IP Right Cessation
- 1989-07-25 ES ES89810565T patent/ES2062092T3/es not_active Expired - Lifetime
- 1989-07-25 EP EP89810565A patent/EP0357550B1/en not_active Expired - Lifetime
- 1989-07-25 DE DE68913397T patent/DE68913397T2/de not_active Expired - Fee Related
- 1989-07-27 PT PT91302A patent/PT91302B/pt not_active IP Right Cessation
- 1989-07-27 DK DK372089A patent/DK372089A/da not_active Application Discontinuation
- 1989-07-27 AU AU39017/89A patent/AU632487B2/en not_active Ceased
- 1989-07-27 NZ NZ230098A patent/NZ230098A/en unknown
- 1989-07-27 IL IL9112889A patent/IL91128A/en not_active IP Right Cessation
- 1989-07-27 NO NO893062A patent/NO177485C/no unknown
- 1989-07-28 IE IE245989A patent/IE63243B1/en not_active IP Right Cessation
- 1989-07-28 FI FI893616A patent/FI893616A/fi not_active Application Discontinuation
- 1989-07-28 JP JP1194436A patent/JPH0273016A/ja active Pending
- 1989-07-28 CA CA000606986A patent/CA1336503C/en not_active Expired - Fee Related
- 1989-07-28 KR KR1019890010692A patent/KR910002445A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0357550B1 (en) | 1994-03-02 |
NO177485B (no) | 1995-06-19 |
PT91302A (pt) | 1990-02-08 |
EP0357550A2 (en) | 1990-03-07 |
IE63243B1 (en) | 1995-04-05 |
NZ230098A (en) | 1992-02-25 |
NO177485C (no) | 1995-09-27 |
NO893062L (no) | 1990-01-30 |
FI893616A (fi) | 1990-01-30 |
HU206040B (en) | 1992-08-28 |
ES2062092T3 (es) | 1994-12-16 |
FI893616A0 (fi) | 1989-07-28 |
JPH0273016A (ja) | 1990-03-13 |
CA1336503C (en) | 1995-08-01 |
KR910002445A (ko) | 1991-02-25 |
EP0357550A3 (en) | 1991-04-03 |
PT91302B (pt) | 1995-03-01 |
DE68913397D1 (de) | 1994-04-07 |
AU632487B2 (en) | 1993-01-07 |
DE68913397T2 (de) | 1994-08-11 |
IL91128A (en) | 1996-01-31 |
HUT50630A (en) | 1990-03-28 |
NO893062D0 (no) | 1989-07-27 |
IE892459L (en) | 1990-01-29 |
AU3901789A (en) | 1990-02-01 |
US4910206A (en) | 1990-03-20 |
IL91128A0 (en) | 1990-03-19 |
DK372089D0 (da) | 1989-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK344485A (da) | Anvendelse af chromanderivater | |
DK344585A (da) | Anvendelse af chromanderivater | |
DK84789A (da) | Isoquinolinderivater | |
DK5789D0 (da) | Isoquinolinderivater | |
DK363887A (da) | Anvendelse af bromcruptin | |
DK486686D0 (da) | Anvendelse af benzamidderivater | |
DK608888D0 (da) | Anvendelse af polysaccharidderivater | |
DK372089D0 (da) | Anvendelse af isoquinolinderivater | |
DK273089D0 (da) | Anvendelse af peptidderivater | |
DK104389A (da) | Anvendelse af imidazolderivater | |
DK120389D0 (da) | Anvendelse af progestin | |
DK104489D0 (da) | Anvendelse af triazolderivater | |
DK87888A (da) | Terapeutisk anvendelse af tindijoddeuteroporfyrin | |
DK316589D0 (da) | Substituerede azacyclohexylderivater af rifamyciner | |
DK562289A (da) | Anvendelse af somatostatiner | |
DK326789D0 (da) | Fremstilling af homonojirimycin-derivater | |
DK289987D0 (da) | Anvendelse af avaron- og avarolderivater | |
DK120689D0 (da) | Komplekser af selen- og tellurderivater | |
DK289887D0 (da) | Anvendelse af avaron- og avarolderivater | |
DK0402857T3 (da) | Anvendelse af 17beta-cyclopropylamino-androsten-derivater | |
IT8847653A0 (it) | Sizzante comprendente 5 - idroscomposizione farmaceutica anoressitrpofano | |
DK333587D0 (da) | Anvendelse af pyridinderivater | |
DK118189A (da) | Anvendelse af piperazinderivat | |
DK689388D0 (da) | Anvendelse af dihydropyridinderivater | |
DK323586A (da) | Anvendelse af hydrazinderivater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |